We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $69.2B Turnover 15.26%
1-Year Est. Return 41.24%
This Fund
S&P 500
This Quarter Est. Return
+25.64%
1 Year Est. Return
+41.24%
3 Year Est. Return
+116.24%
5 Year Est. Return
+151.83%
10 Year Est. Return
+590.13%
AUM
$69.2B
AUM Growth
+$1.61B
Cap. Flow
-$7.07B
Cap. Flow %
-10.23%
Top 10 Hldgs %
46.63%
Holding
2,045
New
180
Increased
582
Reduced
1,148
Closed
132
Avg Time Held
6.4 years
Top 10 Avg Time Held
5.6 years
Top 20 Avg Time Held
5 years

Sector Composition

Rank Sector Weight
1 Technology 28.21%
2 Miscellaneous 27.25%
3 Industrials 6.93%
4 Consumer Staples 6.67%
5 Consumer Discretionary 6.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
DC icon
1826
Dakota Gold
DC
$742M
$65.1K ﹤0.01%
15,290
+2,306
+18% +$12.4K
2024 Q3
7 quarters
AIOT icon
1827
PowerFleet Inc
AIOT
$358M
$64.3K ﹤0.01%
16,780
-1,241
-7% -$4.35K
2024 Q3
7 quarters
SFIX icon
1828
Stitch Fix
SFIX
$354M
$63.3K ﹤0.01%
15,404
-808
-5% -$2.94K
2023 Q2
12 quarters
CABA icon
1829
Cabaletta Bio
CABA
$244M
$62.5K ﹤0.01%
+20,086
New +$66.1K
2026 Q2
0 quarters
MDXG icon
1830
MiMedx Group
MDXG
$569M
$61.1K ﹤0.01%
15,862
-1,295
-8% -$4.73K
2021 Q2
20 quarters
EDIT icon
1831
Editas Medicine
EDIT
$442M
$58.8K ﹤0.01%
18,137
-496
-3% -$1.45K
2016 Q4
38 quarters
CYH icon
1832
Community Health Systems
CYH
$376M
$56.8K ﹤0.01%
17,003
-1,583
-9% -$4.66K
2020 Q2
24 quarters
AVIR icon
1833
Atea Pharmaceuticals
AVIR
$338M
$55.4K ﹤0.01%
11,907
-1,731
-13% -$8.61K
2021 Q1
21 quarters
LXEO icon
1834
Lexeo Therapeutics
LXEO
$252M
$55.2K ﹤0.01%
11,853
-999
-8% -$5.4K
2025 Q4
2 quarters
STLN icon
1835
Starling Oncology
STLN
$674M
$54.4K ﹤0.01%
10,026
-1,535
-13% -$6.45K
2025 Q2
4 quarters
SOC icon
1836
Sable Offshore Corp
SOC
$585M
$54K ﹤0.01%
17,524
-520
-3% -$6.62K
2024 Q3
7 quarters
OVID icon
1837
Ovid Therapeutics
OVID
$478M
$53.9K ﹤0.01%
+20,049
New +$51.7K
2026 Q2
0 quarters
RZLT icon
1838
Rezolute
RZLT
$405M
$53.3K ﹤0.01%
10,258
-236
-2% -$876
2025 Q2
4 quarters
YEXT icon
1839
Yext
YEXT
$714M
$53K ﹤0.01%
11,342
-3,371
-23% -$13.1K
2020 Q2
24 quarters
RCKT icon
1840
Rocket Pharmaceuticals
RCKT
$281M
$52.7K ﹤0.01%
15,421
-1,722
-10% -$5.73K
2020 Q2
24 quarters
RR icon
1841
Richtech Robotics
RR
$236M
$51.7K ﹤0.01%
24,498
-68
-0.3% -$165
2025 Q2
4 quarters
OPTU icon
1842
Optimum Communications Inc
OPTU
$250M
$50.6K ﹤0.01%
34,907
-2,988
-8% -$3.71K
2025 Q2
4 quarters
GSM icon
1843
FerroAtlántica
GSM
$753M
$50.3K ﹤0.01%
15,831
-1,499
-9% -$6.2K
2025 Q2
4 quarters
ACCO icon
1844
Acco Brands
ACCO
$404M
$50.2K ﹤0.01%
12,065
-605
-5% -$2.22K
2020 Q2
24 quarters
XRX icon
1845
Xerox
XRX
$330M
$50K ﹤0.01%
15,983
-1,092
-6% -$2.73K
2013 Q2
52 quarters
XFOR icon
1846
X4 Pharmaceuticals
XFOR
$330M
$49.4K ﹤0.01%
+10,588
New +$43.4K
2026 Q2
0 quarters
ABAT icon
1847
American Battery Technology Co
ABAT
$217M
$48K ﹤0.01%
16,952
-1,106
-6% -$3.54K
2025 Q2
4 quarters
OABI icon
1848
OmniAb
OABI
$740M
$47.1K ﹤0.01%
19,155
-3,397
-15% -$6.74K
2023 Q2
12 quarters
GTN icon
1849
Gray Television
GTN
$438M
$46.2K ﹤0.01%
11,629
-1,121
-9% -$5.16K
2023 Q2
12 quarters
CATX icon
1850
Perspective Therapeutics
CATX
$135M
$46.1K ﹤0.01%
+13,522
New +$51.1K
2026 Q2
0 quarters

Similar funds

ProShare Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, ProShare Advisors held 2,045 positions worth $69.2B, up 2.4% from $67.5B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

ProShare Advisors withdrew a net $7.07B in Q2 2026, closing 132 positions and reducing 1,148 holdings. Its most notable exit was Atlassian, an estimated $14.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 24% a quarter earlier, followed by Miscellaneous and Industrials.

Against the trend, ProShare Advisors opened a new position in Honeywell Aerospace worth $76.5M.

  • ProShare Advisors's largest Q2 2026 buy was Honeywell Aerospace: 346,243 shares worth $76.5M.
  • ProShare Advisors added most to General Dynamics in Q2 2026, an estimated $199M increase.
  • ProShare Advisors's biggest Q2 2026 reduction was ProShares GENIUS Money Market ETF, cutting an estimated $876M.
  • ProShare Advisors fully exited Atlassian in Q2 2026, selling an estimated $14.7M.
  • ProShare Advisors's ten largest holdings make up 47% of its $69.2B portfolio in Q2 2026.
  • ProShare Advisors opened 180 new positions and closed 132 in Q2 2026.
  • ProShare Advisors's portfolio value rose 2.4% quarter-over-quarter to $69.2B.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.